RUNX1 and gastric cancer: Many targets of miR-675 have been proposed in different tumors, such as Twist1 and RB in hepatocellular carcinoma and colorectal cancer [34, 17], CALN1 and RUNX1 in gastric cancer [27, 18], TGFBI in prostate cancer [23].